Network pharmacology combined with molecular docking and experimental validation to explore the potential mechanism of Cinnamomi ramulus against ankylosing spondylitis

References

• Mauro D, Thomas R, Guggino G, et al. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol. 2021;17(7):1–14. doi: 10.1038/s41584-021-00625-y.
   PubMed Web of Science ®Google Scholar
• Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial spondyloarthritis. The New England J Med. 2016;374(26):2563–2574. doi: 10.1056/NEJMra1406182.
   PubMed Web of Science ®Google Scholar
• Danve A, Deodhar A. Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol. 2022;18(4):205–216. doi: 10.1038/s41584-022-00761-z.
   PubMed Web of Science ®Google Scholar
• Ortolan A, Webers C, Sepriano A, et al. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023;82(1):142–152. doi: 10.1136/ard-2022-223297.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang Q, Li RL, et al. The traditional uses, phytochemistry, pharmacology and toxicology of cinnamomi ramulus: a review. J Pharm Pharmacol. 2020;72(3):319–342. doi: 10.1111/jphp.13189.
   PubMed Web of Science ®Google Scholar
• Wu Lizheng CK, Jingyan XIN, Zhenliang WANG. Wang Zhen-liang’s experience of treating ankylosing spondylitis. Henan Tradit Chin Med. 2019;39(3):350–353. doi: 10.16367/j.issn.1003-5028.2019.03.0087.
   Google Scholar
• Hou Kun ZQ, Peipei SHAO, Shi Y, et al. Effect of Yishen Tongdu mixture combined with Du meridian moxibustion on curative effect, lumbar function and immune function of patients with ankylosing spondylitis. Liaoning JTradit Chin Med. 2022;49(1):146–149. doi: 10.13192/j.issn.1000-1719.2022.01.042.
   Google Scholar
• Noor F, Tahir Ul Qamar M, Ashfaq UA, et al. Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals. 2022;15(5):572. doi: 10.3390/ph15050572.
   Web of Science ®Google Scholar
• Ma X, Zhang X, Kong Y, et al. Therapeutic effects of panax notoginseng saponins in rheumatoid arthritis: network pharmacology and experimental validation. Bioengineered. 2022;13(6):14438–14449. doi: 10.1080/21655979.2022.2086379.
   PubMed Web of Science ®Google Scholar
• Roskoski R.Jr. Rule of five violations among the FDA-approved small molecule protein kinase inhibitors. Pharmacol Res. 2023;191:106774. doi: 10.1016/j.phrs.2023.106774.
   PubMed Web of Science ®Google Scholar
• Xu HY, Zhang YQ, Liu ZM, et al. ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res. 2019;47(D1):D976–d82. doi: 10.1093/nar/gky987.
   PubMed Web of Science ®Google Scholar
• Ji KY, Liu C, Liu ZQ, et al. Comprehensive assessment of nine target prediction web services: which should we choose for target fishing? Briefings Bioinf. 2023;24(2):bbad014. doi: 10.1093/bib/bbad014.
   Web of Science ®Google Scholar
• Huang X, Rehman HM, Szöllősi AG, et al. Network pharmacology-based approach combined with bioinformatic analytics to elucidate the potential of curcumol against hepatocellular carcinoma. Genes. 2022;13(4):653. doi: 10.3390/genes13040653.
   Web of Science ®Google Scholar
• Tarek A, Mohamed HT, El-Sharkawy AA, et al. Differential gene expression of fresh tissue and patient-derived explants’ matricellular proteins augment inflammatory breast cancer metastasis: the possible role of IL-6 and MCP-1. QJM: mon J Assoc Physicians. 2023;116(5):345–354. doi: 10.1093/qjmed/hcac284.
   Google Scholar
• Di H, Liu H, Xu S, et al. Network pharmacology and experimental validation to explore the molecular mechanisms of compound Huangbai liquid for the treatment of acne. Drug Design, Development and Therapy. 2023;17:39–53. doi: 10.2147/dddt.S385208.
   PubMed Web of Science ®Google Scholar
• Eberhardt J, Santos-Martins D, Tillack AF, et al. AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model. 2021;61(8):3891–3898. doi: 10.1021/acs.jcim.1c00203.
   PubMed Web of Science ®Google Scholar
• O’Boyle NM, Banck M, James CA, et al. Open babel: an open chemical toolbox. J Cheminf. 2011;3:33. doi: 10.1186/1758-2946-3-33.
   PubMed Web of Science ®Google Scholar
• Adasme MF, Linnemann KL, Bolz SN, et al. PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 2021;49(W1):W530–w4. doi: 10.1093/nar/gkab294.
   PubMed Web of Science ®Google Scholar
• Zhou C, Liang T, Jiang J, et al. Immune cell infiltration-related clinical diagnostic model for ankylosing spondylitis. Front Genet. 2022;13:949882. doi: 10.3389/fgene.2022.949882.
   PubMed Web of Science ®Google Scholar
• Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 1999;106(5b):37s–42s. doi: 10.1016/s0002-9343(99)00115-1.
   PubMedGoogle Scholar
• Jafarnezhad-Ansariha F, Yekaninejad MS, Jamshidi AR, et al. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line. Inflammo­pharmacology. 2018;26(2):375–384. doi: 10.1007/s10787-017-0386-4.
   PubMed Web of Science ®Google Scholar
• An Y, Yao J, Niu X. The signaling pathway of PGE(2) and its regulatory role in T cell differentiation. Mediators Inflamm. 2021;2021:9087816–9087817. doi: 10.1155/2021/9087816.
   PubMedGoogle Scholar
• Kroon FP, van der Burg LR, Ramiro S, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015;2015(7):Cd010952. doi: 10.1002/14651858.CD010952.pub2.
   PubMedGoogle Scholar
• Van den Steen PE, Dubois B, Nelissen I, et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2002;37(6):375–536. doi: 10.1080/10409230290771546.
   PubMed Web of Science ®Google Scholar
• Mattey DL, Packham JC, Nixon NB, et al. Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. Arthritis Res Ther. 2012;14(3):R127. doi: 10.1186/ar3857.
   PubMed Web of Science ®Google Scholar
• Qin H, Wu T, Liu J, et al. MALT-1 inhibition attenuates the inflammatory response of ankylosing spondylitis by targeting NF-κB activation. Injury. 2021;52(6):1287–1293. doi: 10.1016/j.injury.2021.03.053.
   PubMed Web of Science ®Google Scholar
• Yu W, Chen K, Ye G, et al. SNP-adjacent super enhancer network mediates enhanced osteogenic differentiation of MSCs in ankylosing spondylitis. Hum Mol Genet. 2021;30(3-4):277–293. doi: 10.1093/hmg/ddaa272.
   PubMed Web of Science ®Google Scholar
• Gupta L, Bhattacharya S, Aggarwal A. Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis. Clin Rheumatol. 2018;37(5):1401–1405. doi: 10.1007/s10067-017-3938-5.
   PubMed Web of Science ®Google Scholar
• Herzmann N, Salamon A, Fiedler T, et al. Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mesenchymal stromal cells in vitro via TLR4 activation. Exp Cell Res. 2017;350(1):115–122. doi: 10.1016/j.yexcr.2016.11.012.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhou J, Ruan A, et al. Cinnamic aldehyde, the main monomer component of cinnamon, exhibits anti-inflammatory property in OA synovial fibroblasts via TLR4/MyD88 pathway. J Cell Mol Med. 2022;26(3):913–924. doi: 10.1111/jcmm.17148.
   PubMed Web of Science ®Google Scholar
• Almoiliqy M, Wen J, Qaed E, et al. Protective effects of cinnamaldehyde against mesenteric ischemia-reperfusion-induced lung and liver injuries in rats. Oxid Med Cell Longevity. 2020;2020:4196548. doi: 10.1155/2020/4196548.
   PubMed Web of Science ®Google Scholar
• Golshahi H, Araghi A, Baghban F, et al. Protective effects of 2-methoxycinnamaldehyde an active ingredients of cinnamomum cassia on warm hepatic ischemia reperfusion injury in rat model. Iran J Basic Med Sci. 2019;22(12):1400–1407. doi: 10.22038/ijbms.2019.13987.
   PubMed Web of Science ®Google Scholar
• Jin YH, Kim SA. 2-Methoxycinnamaldehyde inhibits the TNF-α-induced proliferation and migration of human aortic smooth muscle cells. Int J Mol Med. 2017;39(1):191–198. doi: 10.3892/ijmm.2016.2818.
   PubMed Web of Science ®Google Scholar
• Diao M, Peng J, Wang D, et al. Peripheral vitamin D levels in ankylosing spondylitis: a systematic review and meta-analysis. Front Med. 2022;9:972586. doi: 10.3389/fmed.2022.972586.
   Web of Science ®Google Scholar
• Zhang GN, Xu YJ, Jin L. Peptidomics analysis of plasma in patients with ankylosing spondylitis. Front Immunol. 2023;14:1104351. doi: 10.3389/fimmu.2023.1104351.
   PubMed Web of Science ®Google Scholar
• Kiranatlioglu-Firat F, Demir H, Cuce I, et al. Increased oxidative and chromosomal DNA damage in patients with ankylosing spondylitis: its role in pathogenesis. Clin Exp Med. 2022;23(5):1721–1728. doi: 10.1007/s10238-022-00957-3.;
   PubMed Web of Science ®Google Scholar
• Xu H, Yu H, Liu L, et al. Integrative single-cell RNA-seq and ATAC-seq analysis of peripheral mononuclear cells in patients with ankylosing spondylitis. Front Immunol. 2021;12:760381. doi: 10.3389/fimmu.2021.760381.
   PubMed Web of Science ®Google Scholar
• Wendling D, Cedoz JP, Racadot E, et al. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Jt Bone Spine. 2007;74(3):304–305. doi: 10.1016/j.jbspin.2006.11.005.
   PubMed Web of Science ®Google Scholar
• Pinto LG, Cunha TM, Vieira SM, et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain. 2010;148(2):247–256. doi: 10.1016/j.pain.2009.11.006.
   PubMed Web of Science ®Google Scholar
• Wendling D, Verhoeven F, Prati C. Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis. Expert Opin Biol Ther. 2019;19(1):55–64. doi: 10.1080/14712598.2019.1554053.
   PubMed Web of Science ®Google Scholar
• Roozbehkia M, Mahmoudi M, Aletaha S, et al. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB signaling pathway in ankylosing spondylitis patients. Int Immunopharmacol. 2017;52:191–196. doi: 10.1016/j.intimp.2017.08.018.
   PubMed Web of Science ®Google Scholar
• Lata M, Hettinghouse AS, Liu CJ. Targeting tumor necrosis factor receptors in ankylosing spondylitis. AnnN Y Acad Sci. 2019;1442(1):5–16. doi: 10.1111/nyas.13933.
   PubMed Web of Science ®Google Scholar
• Hess K, Ushmorov A, Fiedler J, et al. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone. 2009;45(2):367–376. doi: 10.1016/j.bone.2009.04.252.
   PubMed Web of Science ®Google Scholar
• Leone GM, Mangano K, Petralia MC, et al. Past, present and (foreseeable) future of biological anti-TNF alpha therapy. J Clin Med. 2023;12(4):1630. doi: 10.3390/jcm12041630.
   Web of Science ®Google Scholar
• Zhang J, Xu R, Wu L, et al. Expression and function of toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis. Mol Med Rep. 2019;20(4):3565–3572. doi: 10.3892/mmr.2019.10631.
   PubMed Web of Science ®Google Scholar